Sec. 51.0004. REIMBURSEMENT REQUIREMENTS; NOTICE. (a) A reimbursement under the program must: (1) be reviewed and approved by the institutional review board associated with the cancer clinical trial for which the reimbursement is provided; and (2) comply with applicable federal and state laws. (b) The independent, third-party organization operating the program is not required to obtain approval from an institutional review board on the financial eligibility of a subject who is medically eligible for the program. (c) The independent, third-party organization operating the program shall provide written notice to a subject on: (1) the nature and availability of the ancillary financial support under the program; and (2) the program's general guidelines on financial eligibility. Redesignated by Acts 2021, 87th Leg., R.S., Ch. 915 (H.B. 3607 ), Sec. 21.001(53), eff. September 1, 2021.
‹ Prev All Texas sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.